Remede® System
FDA premarket approval P160039/S002 · decided 2018-11-02
Approval details
- PMA number
- P160039
- Supplement
- S002
- Supplement type
- Normal 180 Day Track
- Supplement reason
- Change Design/Components/Specifications/Material
- Trade name
- Remede® System
- Generic name
- Implanted phrenic nerve stimulator for central sleep apnea
- Applicant
- Respicardia
- Date received
- 2018-02-27
- Decision date
- 2018-11-02
- Days to decision
- 248 days
- Decision code
- APPR
- Product code
- PSR
- Advisory committee
- Anesthesiology
- Expedited review
- No
- Location
- Minnetonka, MN
- Statement
- Approval for an update to the tablet hardware and software of the Model 1002A Remede System Programmer.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.
510(k) clearances by this applicant
| Record | Firm | Date |
|---|---|---|
| RESPIGUIDE DELIVERY SYSTEM (K130378) | Respicardia | 2013-10-17 |